It’s no secret that there are competitors and companies trying to develop competing CRC blood based tests. Rhythm has developed a test, it has excellent sensitivity and specificity, and is soon to have a TGA outcome. In recent months a second test manufacturing site has been secured. There’s a relatively good chance that deals are in the pipeline and/or at various advanced stages and commercialisation is in the not too distance future. Glenn has repeatedly said revenue will come in FY23. Another program developing tests for other cancers on the platform is underway. It’s an pan cancerous biomarker. There are many competitors also in this space for these cancers. We are all aware of the risks involved in this investment.
People such as borano come along with a “sell” sentiment and who don’t hold the stock and show little credibility and start a new thread spamming various competitors every five minutes. We know that there are and will continue to be competitors in this space. And we know that borano has stopped disclosing the names of companies in all these new threads being created because he was shot down as his research was a joke to put it politely. So borano has now stopped disclosing company names as every other time he did his research quickly fell to pieces as it didn’t amount to anything.
What kind of person does this? What are his motives given that he is prepared to go to such lengths and dedicate so much time to a company he doesn’t hold? He certainly doesn’t want to help anyone because he isn’t disclosing what information he believes he has. But I suppose all the information he previously disclosed amounted to nothing be a red face. If it was genuine information he would have disclosed it as he had in the past.
I won’t be selling a single share of mine this close to the TGA ann and prospects of FY23 revenue that Glenn has stated. And by the looks of the SP in recent months and weeks, I’m not alone.
I also note that the depth on the sell side is looking quite thin recently. A positive from $1.10 there is a gap up to 1.20. There is around 44,000 units between the closing price and 1.20.
